Apotex Inc., a leading name in the pharmaceutical preparation manufacturing industry, is headquartered in Canada and operates extensively across North America and globally. Founded in 1974, Apotex has established itself as a pioneer in the development and production of high-quality generic pharmaceuticals, offering a diverse portfolio that includes over 300 products across various therapeutic areas.
Renowned for its commitment to affordability and accessibility, Apotex stands out with its robust research and development capabilities, ensuring that it meets the evolving needs of patients and healthcare providers. The company has achieved significant milestones, including numerous FDA approvals, solidifying its position as a trusted supplier in the competitive pharmaceutical landscape. With a focus on innovation and quality, Apotex continues to make a meaningful impact on global health.
-10 vs industry average
Apotex’s score of 29 is lower than 44% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Apotex?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
Apotex's reported carbon emissions
Apotex, a pharmaceutical preparation manufacturer headquartered in CA, has been reporting its carbon emissions since 2018. In 2023, the company reported Scope 1 emissions of approximately 40.2 million kg CO2e and Scope 2 emissions of approximately 15.6 million kg CO2e. This represents a decrease from 2018, when Scope 1 emissions were about 44.8 million kg CO2e and Scope 2 emissions were approximately 20.9 million kg CO2e. Apotex’s total reported emissions for 2023, encompassing Scope 1 and Scope 2, were approximately 55.8 million kg CO2e.
While specific overall reduction targets are not yet publicly detailed, Apotex is actively evaluating decarbonisation pathways. The company aims to establish near-term emissions reduction targets between 2023 and 2025, covering both Scope 1 and Scope 2 emissions. Apotex acknowledges that Scope 3 emissions, particularly purchased goods and services, are a missing data point in their current reporting.
It is important to note that Apotex's emissions data is cascaded from its parent organisation, Apotex Inc., at cascade level 4.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Apotex’s Climate Goals (2030 & 2050)
2 goals2025
We are evaluating potential pathways to decarbonization, whi…
We are evaluating potential pathways to decarbonization, which will enable decision-making on the rigour and timeline of setting near-term e…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Apotex
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project